US 12,150,928 B2
Methods of treating sarin exposure with tetrahydrocannabinol and cannabidiol combinations
Joseph Morgan, Yardley, PA (US)
Assigned to Kotzker Consulting LLC, Yardley, PA (US)
Filed by KOTZKER CONSULTING LLC, Yardley, PA (US)
Filed on Jan. 31, 2022, as Appl. No. 17/589,012.
Application 17/589,012 is a division of application No. 16/004,004, filed on Jun. 8, 2018, granted, now 11,266,623.
Application 16/004,004 is a continuation of application No. 14/649,951, abandoned, previously published as PCT/US2013/076223, filed on Dec. 18, 2013.
Claims priority of provisional application 61/738,782, filed on Dec. 18, 2012.
Prior Publication US 2022/0151981 A1, May 19, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/352 (2006.01); A61K 31/00 (2006.01); A61K 31/01 (2006.01); A61K 31/015 (2006.01); A61K 31/045 (2006.01); A61K 31/05 (2006.01); A61K 31/4425 (2006.01); A61K 31/46 (2006.01); A61K 31/5513 (2006.01); A61K 31/5517 (2006.01); A61K 45/06 (2006.01); C07D 451/10 (2006.01); C07D 471/08 (2006.01)
CPC A61K 31/352 (2013.01) [A61K 31/01 (2013.01); A61K 31/015 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/4425 (2013.01); A61K 31/46 (2013.01); A61K 31/5513 (2013.01); A61K 31/5517 (2013.01); A61K 31/658 (2023.05); A61K 45/06 (2013.01); C07D 451/10 (2013.01); C07D 471/08 (2013.01)] 16 Claims
 
1. A method for treating symptoms caused by exposure to sarin or aldicarb, comprising: administering a composition comprising about 0.0001 mg to about 10 mg of tetrahydrocannabinol (THC) and about 3 mg to about 400 mg cannabidiol (CBD) to a subject exposed to sarin or aldicarb, wherein the administration of the THC/CBD composition is oral, nasal, buccal, vapor, sublingual, or parenteral.